AR061197A1 - Cepas del virus 3 del dengue vivas atenuadas - Google Patents
Cepas del virus 3 del dengue vivas atenuadasInfo
- Publication number
- AR061197A1 AR061197A1 ARP070102282A ARP070102282A AR061197A1 AR 061197 A1 AR061197 A1 AR 061197A1 AR P070102282 A ARP070102282 A AR P070102282A AR P070102282 A ARP070102282 A AR P070102282A AR 061197 A1 AR061197 A1 AR 061197A1
- Authority
- AR
- Argentina
- Prior art keywords
- atenuadas
- cepas
- vivas
- dengue virus
- attenuated dengue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24161—Methods of inactivation or attenuation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La invencion se refiere a cepas del virus de serotipo 3 del dengue vivas atenuadas las cuales han sido producidas por mutagénesis dirigida al sitio de una cepa del dengue 3 atenuada.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80410106P | 2006-06-07 | 2006-06-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR061197A1 true AR061197A1 (es) | 2008-08-13 |
Family
ID=38544276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070102282A AR061197A1 (es) | 2006-06-07 | 2007-05-28 | Cepas del virus 3 del dengue vivas atenuadas |
Country Status (3)
Country | Link |
---|---|
US (1) | US20080107685A1 (es) |
AR (1) | AR061197A1 (es) |
WO (1) | WO2007141259A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2909286B1 (fr) * | 2006-12-01 | 2012-06-08 | Sanofi Pasteur | Methode d'immunisation contre les 4 serotypes de la dengue |
EP2473624B1 (en) | 2009-08-31 | 2019-05-01 | Gen-Probe Incorporated | Dengue virus assay |
US8895028B2 (en) | 2012-07-20 | 2014-11-25 | Arbovax, Inc. | Methods and compositions for dengue virus 3 (DV3) infectious clone |
AU2014281713A1 (en) | 2013-06-21 | 2015-11-12 | Merck Sharp & Dohme Corp. | Dengue virus vaccine compositions and methods of use thereof |
WO2016106107A2 (en) | 2014-12-22 | 2016-06-30 | Merck Sharp & Dohme Corp. | Dengue virus vaccine compositions and methods of use thereof |
KR102297300B1 (ko) * | 2015-11-27 | 2021-09-02 | 케이엠 바이올로직스 가부시키가이샤 | 뎅기 바이러스 약독주를 뱅크화한 생바이러스, 및 그것들을 항원으로 하는 뎅기 백신 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000057904A2 (en) * | 1999-03-26 | 2000-10-05 | Walter Reed Army Institute Of Research | Attenuated dengue-3 virus vaccine |
ES2554254T3 (es) * | 2000-02-16 | 2015-12-17 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Quimeras del virus del dengue 2 inmunógenas |
ES2315221T3 (es) * | 2000-05-30 | 2009-04-01 | Mahidol University | Cepas atenuadas del virus del dengue y su utilizacion en una composicion vaccinea. |
-
2007
- 2007-05-28 AR ARP070102282A patent/AR061197A1/es not_active Application Discontinuation
- 2007-06-01 US US11/756,790 patent/US20080107685A1/en not_active Abandoned
- 2007-06-05 WO PCT/EP2007/055504 patent/WO2007141259A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007141259A1 (en) | 2007-12-13 |
US20080107685A1 (en) | 2008-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR061197A1 (es) | Cepas del virus 3 del dengue vivas atenuadas | |
AR053913A1 (es) | Cepa atenuada de dengue serotipo 1 | |
ATE465719T1 (de) | Oral zerfallende zusammensetzung von olanzapin oder donepezil | |
EA201000556A1 (ru) | Спиропирролидины и их применение для борьбы с инфицированием посредством hcv (вирус гепатита с) и вич (вирус иммунодефицита человека) | |
CL2008003723A1 (es) | Cepa de cladosporium cladosporioides, composicion biocida que comprende el microorganismo o sus esporas y metodo para controlar patogenos en hojas, frutos y espigas de plantas. | |
CL2011001277A1 (es) | Compuestos derivados de n-oxiamidas espiroheterociclicas; su proceso de preparacion; composicion insecticida, acaricida, nematicida o molusquicida que comprende a dichos compuestos; metodo para combatir y controlar pestes; y compuestos intermediarios. | |
CR10528A (es) | Proceso para producir poxvirus y composiciones de poxvirus | |
CR11583A (es) | Arilpirrolinas insecticidas | |
UY34983A (es) | Compuestos antivirales eficaces para inhibir la replicación del virus de la hepatitis c ("hcv") y c omposiciones relacionadas | |
CL2011001810A1 (es) | Cepa de saccharomyces cerevisiae; composicion fitosanitaria que la comprende; y procedimiento de tratamiento o proteccion de plantas contra enfermedades provocadas por agentes patogenos. | |
CR11060A (es) | Aril pirrolidinas insecticidas | |
HN2008001393A (es) | Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen | |
GT201200249A (es) | Cepa bacteriana aislada del genero burkholderia y metabolitos pesticidas del mismo | |
CL2011003039A1 (es) | Mezcla sinergica de compuestos fungicidas y una cepa fungicida del genero bacillus spp; mezcla para combatir hongos nocivos fitopatogenos. | |
HN2006014095A (es) | Forma cristalina ortorrombica del maleato de asenapina | |
AR053022A1 (es) | Metodo para mejorar el desarrollo de plantas tolerantes o resistentes a los nematodos | |
CY1114883T1 (el) | Καινοφανεις αντιβακτηριακοι παραγοντες για την αγωγη των κατα gram θετικων λοιμωξεων | |
BRPI0919048B8 (pt) | Composições pesticidas | |
GT200800088A (es) | Procedimiento para la preparacion de ferri-succinilcaseina | |
HN2010001537A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
BRPI0713280A2 (pt) | Combinações de substâncias ativas com propriedades inseticidas e acaricidas | |
RS53907B1 (en) | USE OF NIFURATEL FOR TREATMENT OF ATOPOBIUM-CAUSED INFECTIONS | |
ES2585242T3 (es) | Cepas virales obtenidas del virus vaccinia Lister VACV-107 y usos de las mismas | |
CR11656A (es) | Composiciones fungicidas con 3'-bromo-2,3,4-6'-tetrametoxi-2'-6-dimetilbenzofenona | |
AR060182A1 (es) | Polisacaridos capsulares tipo 5 y tipo 8 de cepas s. aureus de sobreproduccion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |